Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer

REFERENCES

1. 1.↵
   Cancer Facts and Figures 2011. American Cancer Society Web site. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf. Accessed October 28, 2012
2. 2.↵
   1. Agarwal V,
   2. Branstetter B,
   3. Johnson J

   . Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 2008;41:23–49

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Branstetter B,
   2. Blodgett T,
   3. Zimmer L,
   4. et al

   . Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580–86

   PubMedWeb of Science
4. 4.↵
   1. Andrade RS,
   2. Heron DE,
   3. Degirmenci B,
   4. et al

   . Post-treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2006;65:1315–22

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Goerres GW,
   2. Schmid D,
   3. Bandhauer F,
   4. et al

   . Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105–09

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Porceddu SV,
   2. Jarmolowski D,
   3. Hicks RJ,
   4. et al

   . Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)-radiotherapy in head and neck cancer. Head Neck 2005;27:175–81

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Zimmer L,
   2. Snyderman C,
   3. Fukui M,
   4. et al

   . The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J 2005;84:104,106,108–110

   PubMed
8. 8.↵
   National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#head-and-neck. Accessed October 28, 2012
9. 9.↵
   1. Beswick DM,
   2. Gooding WE,
   3. Johnson JT,
   4. et al

   . Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring. Laryngoscope 2012;122:1512–17

   CrossRefPubMed
10. 10.↵
    1. Yao M,
    2. Graham MM,
    3. Smith RB,
    4. et al

    . Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 2004;60:1410–18

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Ong SC,
    2. Schoder H,
    3. Lee NY,
    4. et al

    . Clinical utility of ¹⁸F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008;49:532–40

    Abstract/FREE Full Text
12. 12.↵
    1. Nayak JV,
    2. Walvekar RR,
    3. Andrade RS,
    4. et al

    . Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129–34

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Kubota K,
    2. Yokoyama J,
    3. Yamaguchi K,
    4. et al

    . FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004:31:590–95

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Ryan WR,
    2. Fee WE,
    3. Le QT,
    4. et al

    . Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645–50

    PubMedWeb of Science
15. 15.↵
    1. Brkovich V,
    2. Miller F,
    3. Karnad A,
    4. et al

    . The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006;116:855–58

    PubMedWeb of Science
16. 16.↵
    1. Greven K,
    2. Williams D,
    3. McGuirt W,
    4. et al

    . Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001;23:942–46

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Rodrigues RS,
    2. Bozza FA,
    3. Christian PE,
    4. et al

    . Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 2009;50:1205–13

    Abstract/FREE Full Text